2022 Q3 Form 10-Q Financial Statement

#000121390022047447 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.113M $313.0K $577.1K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.113M $313.0K $577.1K
YoY Change 3708423.33% 31200.0%
Operating Profit -$1.113M
YoY Change
Interest Expense $349.0K $104.4K $7.780K
YoY Change
% of Operating Profit
Other Income/Expense, Net $349.0K $104.3K $7.777K
YoY Change
Pretax Income -$763.6K -$208.7K -$569.3K
YoY Change
Income Tax $52.58K
% Of Pretax Income
Net Earnings -$816.1K -$208.7K -$569.3K
YoY Change 2720343.33% 20765.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.08 -$20.96K -$58.51K
COMMON SHARES
Basic Shares Outstanding 10.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $436.4K $791.2K $900.6K
YoY Change
Cash & Equivalents $436.4K $791.2K $900.5K
Short-Term Investments
Other Short-Term Assets $12.42K $138.2K $260.9K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $448.8K $929.3K $1.161M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $5.000M $5.000M
YoY Change
Long-Term Investments $78.51M $77.39M $77.28M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $78.51M $77.39M $77.28M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $448.8K $929.3K $1.161M
Total Long-Term Assets $78.51M $77.39M $77.28M
Total Assets $78.96M $78.32M $78.45M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $727.7K $122.3K $18.50K
YoY Change
Accrued Expenses $131.4K $81.39K $110.8K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $772.8K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.884M $426.2K $345.3K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.705M $2.705M $2.705M
YoY Change
Total Long-Term Liabilities $2.705M $2.705M $2.705M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.884M $426.2K $345.3K
Total Long-Term Liabilities $2.705M $2.705M $2.705M
Total Liabilities $4.588M $3.131M $3.050M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$3.889M -$2.090M
YoY Change
Common Stock $228.00 $228.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.889M -$2.089M -$1.881M
YoY Change
Total Liabilities & Shareholders Equity $78.96M $78.32M $78.45M
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$816.1K -$208.7K -$569.3K
YoY Change 2720343.33% 20765.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$354.8K -$109.4K -$300.4K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$772.8K $0.00 -$2.277M
YoY Change
Cash From Investing Activities -$772.8K $0.00 -$2.277M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 772.8K 0.000 2.277M
YoY Change
NET CHANGE
Cash From Operating Activities -354.8K -109.4K -300.4K
Cash From Investing Activities -772.8K 0.000 -2.277M
Cash From Financing Activities 772.8K 0.000 2.277M
Net Change In Cash -354.8K -109.4K -300.4K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$354.8K -$109.4K -$300.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41183
dei Entity Registrant Name
EntityRegistrantName
Welsbach Technology Metals Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
160 S Craig Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Lombard
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60148
dei City Area Code
CityAreaCode
(510)
dei Local Phone Number
LocalPhoneNumber
900-0242
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
WTMA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10011662 shares
CY2022Q2 us-gaap Cash
Cash
791154 usd
CY2021Q4 us-gaap Cash
Cash
1200956 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
138172 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
332633 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
929326 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
1533589 usd
CY2021Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2021Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2021Q4 us-gaap Assets
Assets
76533600 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2625000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
3130910 usd
CY2022Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
77388998 usd
CY2021Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
75000011 usd
CY2022Q2 us-gaap Assets
Assets
78318324 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2765423 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
122265 usd
CY2022Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
222563 usd
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
79673 usd
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
81392 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
60750 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
426220 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
140423 usd
CY2022Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2704690 usd
CY2022Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7727686 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7500000 shares
CY2022Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10
CY2022Q2 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
77276860 usd
CY2021Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
75000000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2283976 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2503750 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2503750 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
250 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2089674 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1232073 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2089446 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1231823 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78318324 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76533600 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
263000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
790059 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1000 usd
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
50000 usd
us-gaap Other General Expense
OtherGeneralExpense
100000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
313000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-208653 usd
us-gaap Net Income Loss
NetIncomeLoss
-777935 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1231823 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
45540 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
73142 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-198370 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-569282 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1000 usd
us-gaap Operating Expenses
OperatingExpenses
890059 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
104347 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
112124 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
791154 usd
CY2022Q2 wtmau Working Capital Amount
WorkingCapitalAmount
503106 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
104347 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
112124 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1880793 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-208653 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2089446 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
24000 usd
us-gaap Net Income Loss
NetIncomeLoss
-777935 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
112127 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-194461 usd
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
142890 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
122265 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1000 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
20642 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-409804 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2276860 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2276860 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2276860 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
45540 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
45538 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2276862 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-409802 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1200956 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
791154 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
79690 usd
CY2021Q4 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
75000000 usd
CY2022Q2 us-gaap Shares Issued
SharesIssued
347500 shares
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
1125000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.50 pure
wtmau Shares Issued Price Per Shares
SharesIssuedPricePerShares
10
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5000001 usd
wtmau Common Stock Percentage
CommonStockPercentage
0.20 pure
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1 pure
wtmau Financial Term
FinancialTerm
P1Y
wtmau Dissolution Expenses
DissolutionExpenses
100000 usd
CY2022Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P1Y
wtmau Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2022Q2 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
30000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of June 30, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
77276860 usd
us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
75000000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2627413 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2550000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4626437 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4505480 usd
wtmau Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
7253850 usd
wtmau Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
7055480 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
77276860 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
75000000 usd
CY2021Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
usd
CY2022Q2 us-gaap Business Acquisition Preacquisition Contingency Amount Of Settlement
BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
43073 usd
CY2022Q2 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
222563 usd
wtmau Shares Issueds
sharesIssueds
7500000 shares
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
wtmau Initial Public Offering And Over Allotment Description
InitialPublicOfferingAndOverAllotmentDescription
Each Unit consists of one share of common stock and one right to receive one-tenth (1/10) of a share of common stock upon consummation of a Business Combination (each, a “Public Right”).
CY2021Q4 wtmau Private Placement Description
PrivatePlacementDescription
On December 27, 2021, simultaneously with the consummation of the IPO, the Company consummated the issuance and sale (“Private Placement”) of 347,500 Private Placement Units in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,475,000. Each Private Placement Unit consists of one share of common stock and one right to receive one-tenth (1/10) of a share of common stock upon consummation of a Business Combination. 
CY2022Q1 wtmau Aggregate Purchase Price
AggregatePurchasePrice
45540 usd
CY2022Q1 wtmau Founder Shares
FounderShares
224328 shares
wtmau Limited Exception
LimitedException
0.50 pure
CY2022Q1 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
259136 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
30000 usd
CY2022Q2 us-gaap Costs Incurred Asset Retirement Obligation Incurred
CostsIncurredAssetRetirementObligationIncurred
6500 usd
us-gaap Costs Incurred Asset Retirement Obligation Incurred
CostsIncurredAssetRetirementObligationIncurred
13000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1125000 shares
CY2022Q1 wtmau Additional Gross Proceeds
AdditionalGrossProceeds
2276860 usd
wtmau Aggregate If The Underwriters Over Allotment Option
AggregateIfTheUnderwritersOverAllotmentOption
1545537 usd
wtmau Underwriting Discount
UnderwritingDiscount
0.35
CY2022Q2 us-gaap Other Commitments Future Minimum Payments Remainder Of Fiscal Year
OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear
2704690 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2021Q2 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
usd
CY2021Q2 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q2 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001866226

Files In Submission

Name View Source Status
0001213900-22-047447-index-headers.html Edgar Link pending
0001213900-22-047447-index.html Edgar Link pending
0001213900-22-047447.txt Edgar Link pending
0001213900-22-047447-xbrl.zip Edgar Link pending
f10q0622ex31-1_welsbachtech.htm Edgar Link pending
f10q0622ex31-2_welsbachtech.htm Edgar Link pending
f10q0622ex32-1_welsbachtech.htm Edgar Link pending
f10q0622ex32-2_welsbachtech.htm Edgar Link pending
f10q0622_welsbachtech.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0622_welsbachtech_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
wtmau-20220630.xsd Edgar Link pending
wtmau-20220630_def.xml Edgar Link unprocessable
wtmau-20220630_pre.xml Edgar Link unprocessable
wtmau-20220630_lab.xml Edgar Link unprocessable
wtmau-20220630_cal.xml Edgar Link unprocessable